Guirgis, M.; Sala, M.; Palan, R.; Beh, H.; Apikatoa, S.; Zubair, O.; Moroz, P.
Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases Offers 60% Five-Year Overall Survival for Low-Volume Disease. Gastrointest. Disord. 2025, 7, 57.
https://doi.org/10.3390/gidisord7030057
AMA Style
Guirgis M, Sala M, Palan R, Beh H, Apikatoa S, Zubair O, Moroz P.
Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases Offers 60% Five-Year Overall Survival for Low-Volume Disease. Gastrointestinal Disorders. 2025; 7(3):57.
https://doi.org/10.3390/gidisord7030057
Chicago/Turabian Style
Guirgis, Mina, Michael Sala, Ranesh Palan, Han Beh, Sharie Apikatoa, Omar Zubair, and Paul Moroz.
2025. "Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases Offers 60% Five-Year Overall Survival for Low-Volume Disease" Gastrointestinal Disorders 7, no. 3: 57.
https://doi.org/10.3390/gidisord7030057
APA Style
Guirgis, M., Sala, M., Palan, R., Beh, H., Apikatoa, S., Zubair, O., & Moroz, P.
(2025). Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases Offers 60% Five-Year Overall Survival for Low-Volume Disease. Gastrointestinal Disorders, 7(3), 57.
https://doi.org/10.3390/gidisord7030057